Larizza D, Cuccia M, Martinetti M, Maghnie M, Dondi E, Salvaneschi L, Severi F
Department of Pediatrics, University of Pavia, IRCCS Policlinico S. Matteo, Italy.
Clin Endocrinol (Oxf). 1994 Jan;40(1):39-45. doi: 10.1111/j.1365-2265.1994.tb02441.x.
Following the chance observation of congenital adrenal hyperplasia in a patient with Turner's syndrome we decided to evaluate the incidence of 21-hydroxylase deficiency (21-OHD) in patients with Turner's syndrome and in their relatives.
Fifty-two patients with Turner's syndrome (mean age +/- SD 14.7 +/- 5.6 years) and 26 relatives were studied.
17-Hydroxyprogesterone (17-OHP) serum levels before and after i.m. administration of 0.25 mg of ACTH(1-24) were evaluated in patients with Turner's syndrome and relatives. In Turner patients basal testosterone and dehydroepiandrosterone concentrations were determined. The results of ACTH tests were analysed according to HLA class I and II alleles of subjects.
The baseline 17-OHP was in the range of the classical form of 21-OHD in one Turner patient, who had severe clitoral enlargement since birth. In 11 patients the stimulated 17-OHP serum level was higher than in normal controls and similar to that found in 21-OHD heterozygous subjects. Clitoral enlargement was significantly more frequent in patients with high stimulated 17-OHP levels (P < 0.001). The frequency of heterozygous-type responses was higher in Turner subjects (1:4.6) than in the Italian population (1:47 for the classic form and 1:9.5 for the non-classic form of the disease). In our patients the frequencies of HLA antigens and haplotypes, usually associated with 21-OHD, were different compared to the controls. HLA-B8, which is negatively associated to 21-OHD, was less frequent in Turner patients than in controls and absent in those with an elevated 17-OHP level. HLA-B14, B22 and B35 were more frequent, though not significantly so, in Turner patients than in controls and even more so in the group with an elevated 17-OHP level. The same investigations performed in 26 relatives of the Turner patients showed a high frequency of carriers of 21-OHD and three subjects with the cryptic form of the disease.
Although in the literature there are only two reports of the association of Turner's syndrome and 21-OHD, on the basis of our experience this association was more frequent, in the Italian population. Since some of the typical signs of 21-OHD (short final stature, varying degrees of virilization, menstrual irregularities, amenorrhoea, infertility) in patients with Turner's syndrome could also be attributed to the chromosomal abnormality, it is therefore more difficult to diagnose 21-OHD in Turner subjects. Adrenal function should be assessed, at least in the presence of clitoral enlargement, in patients with Turner's syndrome, particularly if their karyotype does not contain a Y chromosome. The hypothesis of the presence of cryptic Y chromosome material in these patients should also be considered.
在偶然观察到一名特纳综合征患者患有先天性肾上腺皮质增生症后,我们决定评估特纳综合征患者及其亲属中21-羟化酶缺乏症(21-OHD)的发生率。
研究了52例特纳综合征患者(平均年龄±标准差14.7±5.6岁)和26名亲属。
对特纳综合征患者及其亲属进行肌内注射0.25mg促肾上腺皮质激素(1-24)前后的血清17-羟孕酮(17-OHP)水平进行评估。测定特纳综合征患者的基础睾酮和脱氢表雄酮浓度。根据受试者的HLA I类和II类等位基因分析促肾上腺皮质激素试验结果。
一名特纳综合征患者的基线17-OHP处于经典型21-OHD范围内,该患者自出生以来阴蒂严重增大。11例患者刺激后的17-OHP血清水平高于正常对照组,与21-OHD杂合子受试者的水平相似。刺激后17-OHP水平高的患者阴蒂增大明显更常见(P<0.001)。特纳综合征患者中杂合子型反应的频率(1:4.6)高于意大利人群(该疾病经典型为1:47,非经典型为1:9.5)。在我们的患者中,通常与21-OHD相关的HLA抗原和单倍型频率与对照组不同。与21-OHD呈负相关的HLA-B8在特纳综合征患者中的频率低于对照组,在17-OHP水平升高的患者中不存在。HLA-B14、B22和B35在特纳综合征患者中的频率高于对照组,虽无显著差异,但在17-OHP水平升高的组中更高。对26名特纳综合征患者的亲属进行的相同调查显示,21-OHD携带者的频率很高,并有3名患者患有隐匿型疾病。
虽然文献中仅有两篇关于特纳综合征与21-OHD关联的报道,但根据我们的经验,在意大利人群中这种关联更为常见。由于特纳综合征患者中21-OHD的一些典型体征(最终身高矮小、不同程度的男性化、月经不规律、闭经、不孕)也可能归因于染色体异常,因此在特纳综合征患者中诊断21-OHD更加困难。对于特纳综合征患者,至少在存在阴蒂增大的情况下,应评估肾上腺功能,特别是当其核型中不包含Y染色体时。还应考虑这些患者存在隐匿性Y染色体物质的假说。